VORTIOXETINE HYDROBROMIDE

ID: ALA2107387

Cas Number: 960203-27-4

PubChem CID: 56843850

Product Number: V129787, Order Now?

Max Phase: Approved

First Approval: 2013

Molecular Formula: C18H23BrN2S

Molecular Weight: 298.46

Molecule Type: Small molecule

Associated Items:

This product is in stock

Names and Identifiers

Synonyms: Lu aa21004 hbr | Lu-aa21004 hydrobromide | Lu AA21004 (HBr) | Vortioxetine hydrobromide|960203-27-4|Vortioxetine HBr|Brintellix|Trintellix|Vortioxetine (Lu AA21004) HBr|Vortioxetine (hydrobromide)|UNII-TKS641KOAY|Lu AA 21004 hydrobromide|Lu aa21004 hbr|TKS641KOAY|Lu-aa21004 hydrobromide|CHEBI:76015|Vortioxetine hydrobromide [USAN]|Voltiocetin hydrobromide|vortioxetine monohydrobromide|LU-AA21004 HBR|Lu AA21004 (HBr)|Vortioxetine.HBr|1-(2-((2,4-Dimethylphenyl)thio)phenyl)piperazine hydrobromide|9Show More

Trade Names(2): Brintellix | Trintellix

Canonical SMILES:  Br.Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1

Standard InChI:  InChI=1S/C18H22N2S.BrH/c1-14-7-8-17(15(2)13-14)21-18-6-4-3-5-16(18)20-11-9-19-10-12-20;/h3-8,13,19H,9-12H2,1-2H3;1H

Standard InChI Key:  VNGRUFUIHGGOOM-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 22 23  0  0  0  0  0  0  0  0999 V2000
  -14.5259  -16.5589    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  -20.3009  -14.9384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -21.0154  -15.3509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -21.0154  -16.1759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -20.3009  -16.5884    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -19.5864  -16.1759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -19.5864  -15.3509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -21.7299  -16.5884    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -18.8719  -16.5884    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -18.8719  -14.9384    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
  -18.8719  -14.1134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -18.1574  -13.7009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -18.1574  -12.8759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -18.8719  -12.4634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -19.5864  -12.8759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -19.5864  -13.7009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -17.4430  -14.1134    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  -17.4430  -14.9384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -16.7285  -15.3509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -16.0140  -14.9384    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  -16.0140  -14.1134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -16.7285  -13.7009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
  2  7  2  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  4  8  1  0
  6  9  1  0
  7 10  1  0
 10 11  1  0
 11 12  1  0
 11 16  2  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 12 17  1  0
 17 18  1  0
 22 17  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
M  END

Associated Targets(Human)

CYP2E1 Tchem Cytochrome P450 2E1 (2174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2B6 Tchem Cytochrome P450 2B6 (1338 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsome (8277 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FMO3 Tbio Dimethylaniline monooxygenase [N-oxide-forming] 3 (9 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2A6 Tchem Cytochrome P450 2A6 (2861 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP1A2 Tchem Cytochrome P450 1A2 (26471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C19 Tchem Cytochrome P450 2C19 (29246 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C8 Tchem Cytochrome P450 2C8 (1492 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

SARS-CoV-2 (38078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rep Replicase polyprotein 1ab (11336 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: YesChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: YesBlack Box: Yes
Chirality: YesAvailability: YesProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 298.46Molecular Weight (Monoisotopic): 298.1504AlogP: 3.86#Rotatable Bonds: 3
Polar Surface Area: 15.27Molecular Species: BASEHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.85CX LogP: 4.76CX LogD: 3.31
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.93Np Likeness Score: -1.11

References

1. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, 
2. Unpublished dataset, 
3. Hvenegaard MG, Bang-Andersen B, Pedersen H, Jørgensen M, Püschl A, Dalgaard L..  (2012)  Identification of the cytochrome P450 and other enzymes involved in the in vitro oxidative metabolism of a novel antidepressant, Lu AA21004.,  40  (7): [PMID:22496396] [10.1124/dmd.112.044610]
4. Hvenegaard MG, Bang-Andersen B, Pedersen H, Jørgensen M, Püschl A, Dalgaard L..  (2012)  Identification of the cytochrome P450 and other enzymes involved in the in vitro oxidative metabolism of a novel antidepressant, Lu AA21004.,  40  (7): [PMID:22496396] [10.1124/dmd.112.044610]
5. Bernhard Ellinger, Denisa Bojkova, Andrea Zaliani, Jindrich Cinatl, Carsten Claussen, Sandra Westhaus, Jeanette Reinshagen, Maria Kuzikov, Markus Wolf, Gerd Geisslinger, Philip Gribbon, Sandra Ciesek.  (2020)  Identification of inhibitors of SARS-CoV-2 in-vitro cellular toxicity in human (Caco-2) cells using a large scale drug repurposing collection,  [10.21203/rs.3.rs-23951/v1]
6. Maria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, Francesca Esposito, Laura Vangeel, Markus Wolf, Bernhard Ellinger, Carsten Claussen, Gerd Geisslinger, Angela Corona, Daniela Iaconis, Carmine Talarico, Candida Manelfi, Rolando Cannalire, Giulia Rossetti, Jonas Gossen, Simone Albani, Francesco Musiani, Katja Herzog, Yang Ye, Barbara Giabbai, Nicola Demitri, Dirk Jochmans, Steven De Jonghe, Jasper Rymenants, Vincenzo Summa, Enzo Tramontano, Andrea R. Beccari, Pieter Leyssen, Paola Storici, Johan Neyts, Philip Gribbon, and Andrea Zaliani.  (2020)  Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen,  [10.6019/CHEMBL4495564]
7. Andrea Zaliani, Laura Vangeel, Jeanette Reinshagen, Daniela Iaconis, Maria Kuzikov, Oliver Keminer, Markus Wolf, Bernhard Ellinger, Francesca Esposito, Angela Corona, Enzo Tramontano, Candida Manelfi, Katja Herzog, Dirk Jochmans, Steven De Jonghe, Winston Chiu, Thibault Francken, Joost Schepers, Caroline Collard, Kayvan Abbasi, Carsten Claussen , Vincenzo Summa, Andrea R. Beccari, Johan Neyts, Philip Gribbon and Pieter Leyssen.  (2020)  Cytopathic SARS-Cov2 screening on VERO-E6 cells in a large repurposing effort,  [10.6019/CHEMBL4495565]
8. European Medicines Agency,